| Date Filed | Type | Description |
| 04/04/2023 |
4
| Belloff Neil S. (General Counsel and Corp Secy) has filed a Form 4 on Acorda Therapeutics, Inc.|
Txns:
| Granted 77,300 options to buy
@ $0.586, valued at
$45.3k
|
|
| 11/09/2021 |
4
| Belloff Neil S. (General Counsel) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 85,000 options to buy
@ $3.74, valued at
$317.9k
|
|
| 11/09/2021 |
3
| Belloff Neil S. (General Counsel) has filed a Form 3 on ACORDA THERAPEUTICS INC |
| 07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2020 |
4
| Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 459 shares
@ $2.53, valued at
$1.2k
Exercised 1,562 restricted stock units
@ $0 |
|
| 07/31/2020 |
4
| Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 459 shares
@ $2.84, valued at
$1.3k
Exercised 1,563 restricted stock units
@ $0 |
|
| 05/01/2020 |
4
| Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 459 shares
@ $2.92, valued at
$1.3k
Exercised 1,562 restricted stock units
@ $0 |
|
| 03/04/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| Belloff Neil S. (GENERAL COUNSEL/CORPORATE SECR) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,166 shares
@ $3.91, valued at
$8.5k
Exercised 6,250 restricted stock units
@ $0 |
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2018 |
4
| Belloff Neil S. (General Counsel and Secretary) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $20.85, valued at
$2.6M
|
|
| 06/20/2018 |
3
| Belloff Neil S. (General Counsel and Secretary) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |